Protective effects of AKBA against hypoxia-induced cognitive dysfunction: potential involvement of SLC2A1, PTGS1, and BCL2L1

Introduction Hypoxia-induced cognitive impairment (HICI) is associated with neuroinflammation, oxidative stress, and gut microbiota dysbiosis, highlighting the need for effective neuroprotective interventions. Acetyl-11-keto-β-boswellic acid (AKBA), a bioactive triterpenoid derived from frankincense, possesses anti-inflammatory and antioxidant properties, but its protective effects against hypoxia-associated cognitive dysfunction remain insufficiently understood. Methods This study investigated the neuroprotective potential of AKBA administered concurrently with hypoxic exposure and explored its associated molecular alterations. Network pharmacology, transcriptomic analysis, molecular similarity assessment, molecular docking, and molecular dynamics simulations were integrated to identify and prioritize candidate proteins. The protective effects of AKBA were subsequently evaluated in mice exposed to normobaric hypoxia (12.7% O 2 ) for 10 days. Results AKBA administration attenuated hypoxia-associated cognitive deficits, accompanied by reduced inflammatory and oxidative stress markers, increased BDNF levels, decreased TUNEL-positive staining, and preservation of MBP immunoreactivity. These effects were associated with changes in cortical SLC2A1, PTGS1, and BCL2L1 expression, together with alterations in NF-κB- and Keap1/Nrf2-related protein levels. AKBA administration was also associated with changes in gut microbial composition, and exploratory correlation analyses suggested associations between selected bacterial taxa and cortical protein expression. Conclusion Collectively, these findings indicate that concurrent AKBA administration provides protection against hypoxia-associated cognitive dysfunction, potentially involving coordinated changes in inflammatory, antioxidant, and neurotrophic responses. However, the causal roles of the candidate proteins and gut microbiota alterations remain to be established through further functional investigations.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-06
DOI
https://doi.org/10.3389/fphar.2026.2023356
Primary Topic
Pharmacological Effects of Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Protective effects of AKBA against hypoxia-induced cognitive dysfunction: potential involvement of SLC2A1, PTGS1, and BCL2L1

Liang Gao, Yajun Qiao, Ruiying Cheng, Xingfang Zhang et al.
1 links
Frontiers in Pharmacology
Pharmacological Effects of Medicinal Plants
article

Protective effects of AKBA against hypoxia-induced cognitive dysfunction: potential involvement of SLC2A1, PTGS1, and BCL2L1

Liang Gao, Yajun Qiao, Ruiying Cheng, Xingfang Zhang, Hongtao Bi, Xiaoli Shi, Guoqiang LI, Bowen Lv, Wen Jiang, Yi Ding, Jiayi Wang, Xiaohui Li
article en

Abstract

Introduction Hypoxia-induced cognitive impairment (HICI) is associated with neuroinflammation, oxidative stress, and gut microbiota dysbiosis, highlighting the need for effective neuroprotective interventions. Acetyl-11-keto-β-boswellic acid (AKBA), a bioactive triterpenoid derived from frankincense, possesses anti-inflammatory and antioxidant properties, but its protective effects against hypoxia-associated cognitive dysfunction remain insufficiently understood. Methods This study investigated the neuroprotective potential of AKBA administered concurrently with hypoxic exposure and explored its associated molecular alterations. Network pharmacology, transcriptomic analysis, molecular similarity assessment, molecular docking, and molecular dynamics simulations were integrated to identify and prioritize candidate proteins. The protective effects of AKBA were subsequently evaluated in mice exposed to normobaric hypoxia (12.7% O 2 ) for 10 days. Results AKBA administration attenuated hypoxia-associated cognitive deficits, accompanied by reduced inflammatory and oxidative stress markers, increased BDNF levels, decreased TUNEL-positive staining, and preservation of MBP immunoreactivity. These effects were associated with changes in cortical SLC2A1, PTGS1, and BCL2L1 expression, together with alterations in NF-κB- and Keap1/Nrf2-related protein levels. AKBA administration was also associated with changes in gut microbial composition, and exploratory correlation analyses suggested associations between selected bacterial taxa and cortical protein expression. Conclusion Collectively, these findings indicate that concurrent AKBA administration provides protection against hypoxia-associated cognitive dysfunction, potentially involving coordinated changes in inflammatory, antioxidant, and neurotrophic responses. However, the causal roles of the candidate proteins and gut microbiota alterations remain to be established through further functional investigations.

Frontiers in PharmacologyVol. 17
South Central Minzu University (CN), Chinese Academy of Sciences (CN), Xijing Hospital (CN), Northwest Institute of Plateau Biology (CN), Air Force Medical University (CN)
Good health and well-being
Openalex Percentile: Top 19%
Pharmacological Effects of Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon